Methanexpress Reports Q4 2025 Earnings Miss
- Earnings Miss: Methanexpress reported a Q4 2025 Non-GAAP EPS of -$0.14, missing expectations by $0.79, indicating significant pressure on profitability that could undermine investor confidence.
- Revenue Growth: The company achieved Q4 revenue of $969 million, a 2.1% year-over-year increase, yet fell short of expectations by $61 million, reflecting unmet market demand that may impact future investment decisions.
- Production Outlook: Methanexpress anticipates producing approximately 9.0 million tonnes of methanol and 0.3 million tonnes of ammonia by 2026, although actual production may vary due to gas availability and unforeseen events, introducing uncertainty into long-term strategic planning.
- Adjusted EBITDA Forecast: The company expects a slightly higher Adjusted EBITDA in Q1 2026 compared to Q4 2025, with similar sales volumes but a marginally higher average realized price, indicating a proactive adjustment in pricing strategy that may enhance future financial performance.
Trade with 70% Backtested Accuracy
Analyst Views on MEOH
About MEOH
About the author


Stock Sale Announcement: OCI Chemicals B.V. plans to sell 2 million shares of its common stock on April 9, with a total market value of approximately $123.02 million.
Reduction in Shareholding: Since March 13, 2026, OCI Chemicals B.V. has reduced its shareholding in Methanex (MEOH.U.S) by 3.33 million shares, valued at approximately $172.56 million.

Stock Sale Announcement: OCI Chemicals B.V. plans to sell 2 million shares of its common stock on April 9, with a total market value of approximately $123.02 million.
Reduction in Shareholding: Since March 13, 2026, OCI Chemicals B.V. has reduced its shareholding in Methanex (MEOH.U.S) by 3.33 million shares, valued at approximately $172.56 million.
- Rating Downgrade: RBC Capital Markets downgraded Methanex's rating from outperform to sector perform, despite raising the price target from $55 to $65, indicating that analysts believe recent share gains are increasingly tied to temporary geopolitical factors.
- Price Surge: Methanol prices have surged due to the Iran conflict, with Methanex increasing reference prices across North America, China, and Asia by 33% to over 100%, which could lead to a $173 per metric ton increase in realized pricing, significantly boosting near-term cash flow.
- Improved Earnings Outlook: Despite the downgrade, RBC raised Methanex's financial forecasts, expecting EBITDA to reach approximately $1.34 billion in 2026, up from a prior estimate of $918 million, reflecting stronger pricing power in the market.
- Elevated Risks: RBC highlighted several risks that could impact Methanex's outlook, including further escalation in the Middle East, disruptions to natural gas supply, and a slowdown in global demand, which could negatively affect production and earnings.
- Share Sale Details: OCI N.V.'s wholly owned subsidiary, OCI Chemicals B.V., sold 3,331,346 common shares of Methanex Corp. on March 13 through a block trade, representing approximately 4.3% of the company's outstanding shares, generating net proceeds of about $172.6 million, showcasing OCI's agility in capital management.
- Ownership Change: Prior to the sale, OCI held 9,944,308 shares of Methanex, about 12.9%, and after the transaction, OCI now controls 6,612,962 shares, or about 8.6%, indicating that OCI maintains a significant stake in Methanex, which may continue to influence strategic decisions.
- Market Reaction: OCI's closing price on the Amsterdam Stock Exchange was €3.7500, up 0.81% from the previous trading day, reflecting a positive market response to the share transaction, potentially boosting investor confidence in OCI's future prospects.
- Financial Impact: This transaction not only provides OCI with substantial cash flow but may also be used for further investments or debt repayment, thereby optimizing its capital structure and enhancing the company's financial flexibility and market competitiveness.
- Share Sale Overview: OCI Chemicals B.V. sold 3,331,346 common shares of Methanex (MEOH), representing about 4.3% of the outstanding shares, at a price of $51.80 per share, resulting in net proceeds of approximately $172.6 million after fees.
- Change in Ownership: Following this transaction, OCI now owns or controls 6,612,962 shares of Methanex, which is about 8.6% of the total outstanding shares, indicating a decrease in its stake that may impact its influence in corporate decisions.
- Transaction Timing: The sale was executed as a block trade on March 13, 2026, reflecting OCI's strategic timing in the market to optimize its investment portfolio.
- Market Reaction Potential: While this sale may not have an immediate impact on Methanex's stock price, OCI's divestment could raise market scrutiny on Methanex's future performance, especially given its Q4 2025 earnings report missed expectations.

Stock Sale Announcement: OCI Chemicals B.V. plans to sell 3.33 million shares of its common stock on March 13.
Market Value: The total market value of the shares being sold is approximately $196.02 million.







